Biogen Pharma

Market Cap: Micro Cap
Industry: Non Banking Financial Company (NBFC)
ISIN: INE703D01023
NSEID:
BSEID: 531752

INR

0.73

0.01 (1.39%)

BSENSE

Dec 19

BSE+NSE Vol: 4.25 lacs

{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.73",
    "chg": 0.01,
    "chgp": "1.39%",
    "dir": 1,
    "prev_price": "0.72",
    "mcapval": "65.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE703D01023",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "4.25 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.71",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-falls-to-52-week-low-of-rs071-3751674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3751674.png",
        "date": "2025-12-08 15:11:39",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low, with its stock price touching Rs.0.71 today. This marks a significant milestone as the stock continues to trade below all key moving averages amid a broader market downturn."
      },
      {
        "title": "Biogen Pharma's Evaluation Metrics Revised Amidst Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3749903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharma_mojoScore_3749903.png",
        "date": "2025-12-06 10:10:14",
        "description": "Biogen Pharma, a microcap player in the Non Banking Financial Company (NBFC) sector, has recently undergone a revision in its evaluation metrics reflecting a more cautious market assessment. This shift comes amid persistent operational challenges and subdued financial trends, impacting investor sentiment and stock performance."
      },
      {
        "title": "Why is Biogen Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biogen-pharma-fallingrising-3749495",
        "imagepath": "",
        "date": "2025-12-06 01:16:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Trends and Market Comparison</strong></p>\n<p>Biogen Pharmachem’s stock has been on a downward trajectory over multiple time horizons. Over the past week, the share price declined by 2.63%, contrasting sharply with the Sensex’s marginal gain of 0.01%. This negative momentum intensified over the last month, with the stock falling 8.64% while the Sensex advanced by 2.70%. Year-to-date figures reveal a stark divergence, as Biogen Pharma’s shares have plummeted 37.29%, whereas the Sensex has appreciated by 9.69%. The one-year performance further underscores this disparity, with the stock down 40.80% against the Sensex’s 4.83% gain. Even over a three-year period, Biogen Pharma’s cumulative loss of 11.90% contrasts with the Sensex’s robust 36.41% rise. However, it is notable that over ..."
      },
      {
        "title": "Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.72",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-falls-to-52-week-low-of-rs072-3749209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3749209.png",
        "date": "2025-12-05 15:47:04",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.72 today. This marks a significant decline from its 52-week high of Rs.1.29, reflecting ongoing pressures within the company amid a broader market environment where the Sensex is trading near its yearly peak."
      },
      {
        "title": "Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.73",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-hits-52-week-low-amidst-weak-fundamentals-3744491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3744491.png",
        "date": "2025-12-03 15:36:40",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.73 today. This marks a significant decline over the past year, reflecting ongoing pressures within the company and the broader market environment."
      },
      {
        "title": "Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.74",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-falls-to-52-week-low-of-rs074-3738350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3738350.png",
        "date": "2025-12-01 11:08:47",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low of Rs.0.74, marking a significant decline in its stock price amid broader market gains. The stock has underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial performance."
      },
      {
        "title": "Why is Biogen Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biogen-pharma-fallingrising-3716106",
        "imagepath": "",
        "date": "2025-11-19 22:32:25",
        "description": "As of 19-Nov, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at Rs 0.78, which reflects a decrease of Rs 0.01 or 1.27%. The stock has underperformed significantly, with a 1-week return of -3.70% and a 1-month return of -6.02%. Additionally, it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 3.85% above Rs 0.75. Furthermore, there has been a notable drop in investor participation, with delivery volume falling by 13.13% compared to the 5-day average, indicating reduced interest in trading the stock.\n\nIn the broader market context, Biogen Pharma's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, Biogen's stock has plummeted by 33.90%, while the Sensex has risen by 9.02%. ..."
      },
      {
        "title": "Biogen Pharma Faces Financial Challenges Amidst Mixed Profitability Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-financial-trend-declines-from-flat-to-negative-amid-operational-challenges-3683799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BiogenPharmache_fintrenddot_3683799.png",
        "date": "2025-11-10 08:00:12",
        "description": "Biogen Pharmachem Industries, a microcap in the NBFC sector, reported a flat performance for the quarter ending September 2025, with a decline in financial metrics. Despite a higher profit after tax of Rs 0.85 crore over six months, the company faces significant challenges, including low quarterly profit figures and a substantial stock decline."
      },
      {
        "title": "How has been the historical performance of Biogen Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-biogen-pharma-3683482",
        "imagepath": "",
        "date": "2025-11-09 22:39:21",
        "description": "Answer:\nThe historical performance of Biogen Pharma shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nBiogen Pharma's net sales have remained at zero from March 2023 to March 2025, following a modest increase to 2.47 crore in March 2022 from 1.62 crore in March 2021. Other operating income peaked at 2.38 crore in March 2024 but dropped to zero in March 2025. Total operating income followed a similar trend, reaching 2.16 crore in March 2022 before declining to zero by March 2025. The company faced a total expenditure of 1.13 crore in March 2025, a significant increase from 0.45 crore in March 2024, while operating profit (PBDIT) turned negative at -0.29 crore in March 2025, contrasting with a profit of 1.93 crore in March 2024. Profit before tax also fell to -0.29 crore in March 2025 from 1.93 crore in the previous year. The company's reserves have been negative, reaching -9..."
      }
    ],
    "total": 58,
    "sid": "200854",
    "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 7Th November 2025.",
      "datetime": "07-Nov-2025",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Friday 07th November 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September 2025. The board meeting commented at 03:30 PM and concluded at 04:00 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "07-Nov-2025",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "07-Nov-2025",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.71

2025-12-08 15:11:39

Biogen Pharmachem Industries has reached a new 52-week low, with its stock price touching Rs.0.71 today. This marks a significant milestone as the stock continues to trade below all key moving averages amid a broader market downturn.

Biogen Pharma's Evaluation Metrics Revised Amidst Challenging Market Conditions

2025-12-06 10:10:14

Biogen Pharma, a microcap player in the Non Banking Financial Company (NBFC) sector, has recently undergone a revision in its evaluation metrics reflecting a more cautious market assessment. This shift comes amid persistent operational challenges and subdued financial trends, impacting investor sentiment and stock performance.

Why is Biogen Pharma falling/rising?

2025-12-06 01:16:16

Recent Price Trends and Market Comparison

Biogen Pharmachem’s stock has been on a downward trajectory over multiple time horizons. Over the past week, the share price declined by 2.63%, contrasting sharply with the Sensex’s marginal gain of 0.01%. This negative momentum intensified over the last month, with the stock falling 8.64% while the Sensex advanced by 2.70%. Year-to-date figures reveal a stark divergence, as Biogen Pharma’s shares have plummeted 37.29%, whereas the Sensex has appreciated by 9.69%. The one-year performance further underscores this disparity, with the stock down 40.80% against the Sensex’s 4.83% gain. Even over a three-year period, Biogen Pharma’s cumulative loss of 11.90% contrasts with the Sensex’s robust 36.41% rise. However, it is notable that over ...

Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.72

2025-12-05 15:47:04

Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.72 today. This marks a significant decline from its 52-week high of Rs.1.29, reflecting ongoing pressures within the company amid a broader market environment where the Sensex is trading near its yearly peak.

Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.73

2025-12-03 15:36:40

Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.73 today. This marks a significant decline over the past year, reflecting ongoing pressures within the company and the broader market environment.

Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.74

2025-12-01 11:08:47

Biogen Pharmachem Industries has reached a new 52-week low of Rs.0.74, marking a significant decline in its stock price amid broader market gains. The stock has underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial performance.

Why is Biogen Pharma falling/rising?

2025-11-19 22:32:25

As of 19-Nov, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at Rs 0.78, which reflects a decrease of Rs 0.01 or 1.27%. The stock has underperformed significantly, with a 1-week return of -3.70% and a 1-month return of -6.02%. Additionally, it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 3.85% above Rs 0.75. Furthermore, there has been a notable drop in investor participation, with delivery volume falling by 13.13% compared to the 5-day average, indicating reduced interest in trading the stock. In the broader market context, Biogen Pharma's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, Biogen's stock has plummeted by 33.90%, while the Sensex has risen by 9.02%. ...

Biogen Pharma Faces Financial Challenges Amidst Mixed Profitability Trends

2025-11-10 08:00:12

Biogen Pharmachem Industries, a microcap in the NBFC sector, reported a flat performance for the quarter ending September 2025, with a decline in financial metrics. Despite a higher profit after tax of Rs 0.85 crore over six months, the company faces significant challenges, including low quarterly profit figures and a substantial stock decline.

How has been the historical performance of Biogen Pharma?

2025-11-09 22:39:21

Answer: The historical performance of Biogen Pharma shows significant fluctuations in its financial metrics over the years. Breakdown: Biogen Pharma's net sales have remained at zero from March 2023 to March 2025, following a modest increase to 2.47 crore in March 2022 from 1.62 crore in March 2021. Other operating income peaked at 2.38 crore in March 2024 but dropped to zero in March 2025. Total operating income followed a similar trend, reaching 2.16 crore in March 2022 before declining to zero by March 2025. The company faced a total expenditure of 1.13 crore in March 2025, a significant increase from 0.45 crore in March 2024, while operating profit (PBDIT) turned negative at -0.29 crore in March 2025, contrasting with a profit of 1.93 crore in March 2024. Profit before tax also fell to -0.29 crore in March 2025 from 1.93 crore in the previous year. The company's reserves have been negative, reaching -9...

View All News

Announcement

Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 7Th November 2025.

07-Nov-2025 | Source : BSE

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Friday 07th November 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September 2025. The board meeting commented at 03:30 PM and concluded at 04:00 PM Please take the above intimation in your records. Thanking You.